FDG-PET/CT in oncology

Summary FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented.

[1]  C. Meltzer,et al.  PET/CT: form and function. , 2007, Radiology.

[2]  Ursula Nestle,et al.  Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  W. Weber.  Positron emission tomography as an imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Beyer,et al.  Putting ‘clear’ into nuclear medicine: a decade of PET/CT development , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Johannes Czernin,et al.  Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  M. Petzsch,et al.  Kontrastmittel-induzierte Nephropathie , 2005 .

[8]  R. Castillo,et al.  Attenuation correction of PET images with respiration-averaged CT images in PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  Thomas Beyer,et al.  Respiration artifacts in whole-body 18F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  Branislav Jeremic,et al.  Positron Emission Tomography for Radiation Treatment Planning , 2005, Strahlentherapie und Onkologie.

[11]  R. Coleman,et al.  Concurrent PET/CT with an integrated imaging system: intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  K. Hausegger,et al.  Kurz kommentiert - Clinical Experience with a Commercially Available Negative Oral Contrast Medium in PET/CT , 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[13]  S. Holm,et al.  PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Osman Ratib,et al.  Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Thomas Beyer,et al.  Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Osman Ratib,et al.  Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  Jason P Fine,et al.  Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  P. Vernon,et al.  Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  A. Pevsner,et al.  The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  R. Hustinx,et al.  Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  J. Debatin,et al.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. , 2003, JAMA.

[22]  Thomas Beyer,et al.  PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.

[23]  Thomas Beyer,et al.  X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. , 2003, Seminars in nuclear medicine.

[24]  Yuji Nakamoto,et al.  Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. , 2003, Radiology.

[25]  Cyrill Burger,et al.  Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  R. Wahl,et al.  Initial experience with oral contrast in PET/CT: phantom and clinical studies. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  Yuji Nakamoto,et al.  Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  Snmts.  Fusion imaging: a new type of technologist for a new type of technology. July 31, 2002. , 2002, Journal of nuclear medicine technology.

[29]  Gerald Antoch,et al.  Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  Stephen R Thomas,et al.  MIRD dose estimate report no. 19: radiation absorbed dose estimates from (18)F-FDG. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[34]  Heinrich R Schelbert,et al.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  G. Antoch,et al.  How much CT do we need for PET/CT? , 2005, Nuklearmedizin.

[36]  Richard L Wahl,et al.  Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  G. V. von Schulthess,et al.  Why most PET of lung and head-and-neck cancer will be PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  G. Brix,et al.  Festlegung und Anwendung diagnostischer Referenzwerte für nuklearmedizinische Unter-suchungen in Deutschland , 2004 .